AR010178A1 - Preparados farmaceuticos que contienen como principio activo cilansetron, empleo de aditivos y procedimiento para la produccion de dichos preparados - Google Patents
Preparados farmaceuticos que contienen como principio activo cilansetron, empleo de aditivos y procedimiento para la produccion de dichos preparadosInfo
- Publication number
- AR010178A1 AR010178A1 ARP980102904A ARP980102904A AR010178A1 AR 010178 A1 AR010178 A1 AR 010178A1 AR P980102904 A ARP980102904 A AR P980102904A AR P980102904 A ARP980102904 A AR P980102904A AR 010178 A1 AR010178 A1 AR 010178A1
- Authority
- AR
- Argentina
- Prior art keywords
- applicant
- submitted
- disquette
- acids
- salts
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
Abstract
Se describen preparados farmacéuticos solidos y líquidos que contienen Cilaprincipio activo o sus sales por adicion de ácidos, que contienen una cantidad dcarácter ácido soluble en agua y fisiologicamente compatible suficiente para la de Cilansetroncontra la recemizacion, elegido de ácidos monobásicos o polibásiccon 2 a 12 átomos de carbono y un primer valor de pKs entre 1,1 y 4,8, sales de de los ácidos orgánicos polibásicos antes mencionados y sales de carácter ácidominerales polibásicos conun primer valor de pKs disponible entre 1,5 y 7,5. Addescribe el empleo de los aditivos de carácter ácido para la estabilizacion de Ccontra la racemizacion en preparados farmacéuticos DATOS DEL DISQUETTE PRESENTADO PORE L SOLICITANTEDATOS DEL DISQUETTE PRESENTADO POR EL SOLICITANTE DATOS DEL DISQUETTE PRESENTADO POR EL SOLICITANTEDATOS DEL DISQUETTE PRESENTADO POR EL SOLICITANTE DATOS DEL DISQUETTEPRESENTA DO POR EL SOLICITANTEDATOS DEL DISQUETTE PRESENTADO POR EL SOLICITANTE DATOS DEL DISQUETTE PRESENTADO POR EL SOLICITANTEDATOS DEL DISQUETTE PRESENTADO POR EL SOLICITANTE DATOS DELDISQUETTE PRESENTADO POR EL SOLICITANTEDATOS DEL DISQUETTE PRESENTADO POR EL SOLICITANTE DATOS DEL DISQUETTE PRESENTADO POR EL SOLICITANTEDATOS DEL DISQUETTE PRESENTADO POR EL SOLICITANTE DATOS DEL DI SQUETTE PRESENTADOPOR EL SOLICITANTEDATOS DEL DISQUETTE PRESENTADO POR EL SOLICITANTE DATOS DEL DISQUETTE PRESENTADO POR EL SOLICITANTE
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19733271 | 1997-08-01 | ||
DE19813661A DE19813661A1 (de) | 1997-08-01 | 1998-03-27 | Gegen Racemisierung stabilisierte pharmazeutische Zubereitungen von Cilansetron |
Publications (1)
Publication Number | Publication Date |
---|---|
AR010178A1 true AR010178A1 (es) | 2000-05-17 |
Family
ID=7837672
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP980102904A AR010178A1 (es) | 1997-08-01 | 1998-06-18 | Preparados farmaceuticos que contienen como principio activo cilansetron, empleo de aditivos y procedimiento para la produccion de dichos preparados |
Country Status (29)
Country | Link |
---|---|
US (1) | US5977127A (es) |
EP (1) | EP0895782B1 (es) |
JP (1) | JP4324260B2 (es) |
KR (1) | KR100515201B1 (es) |
CN (1) | CN1117565C (es) |
AR (1) | AR010178A1 (es) |
AT (1) | ATE283706T1 (es) |
AU (1) | AU743043B2 (es) |
BR (1) | BR9803730A (es) |
CA (1) | CA2244389C (es) |
CZ (1) | CZ295072B6 (es) |
DE (2) | DE19813661A1 (es) |
DK (1) | DK0895782T3 (es) |
DZ (1) | DZ2560A1 (es) |
ES (1) | ES2234051T3 (es) |
HK (1) | HK1017611A1 (es) |
HU (1) | HUP9801712A3 (es) |
ID (1) | ID20685A (es) |
IL (1) | IL125403A (es) |
NO (1) | NO323229B1 (es) |
NZ (1) | NZ331083A (es) |
PL (1) | PL191767B1 (es) |
PT (1) | PT895782E (es) |
RU (1) | RU2199318C2 (es) |
SK (1) | SK284916B6 (es) |
TR (1) | TR199801432A3 (es) |
TW (1) | TW509570B (es) |
UA (1) | UA62924C2 (es) |
ZA (1) | ZA986715B (es) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7452545B2 (en) * | 2001-11-13 | 2008-11-18 | Yu Ruey J | Oligosaccharide aldonic acids and their topical use |
US20040077232A1 (en) * | 2001-03-26 | 2004-04-22 | Andreas Ebner | Pharmaceutical compositions |
GB0216027D0 (en) * | 2002-07-10 | 2002-08-21 | Arachnova Therapeutics Ltd | New therapeutic use |
US20040048874A1 (en) * | 2001-05-22 | 2004-03-11 | Bardsley Hazel Judith | New therapeutic use of 4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno[2,3-D]pyrimidine |
BRPI0406749A (pt) * | 2003-01-13 | 2005-12-20 | Dynogen Pharmaceuticals Inc | Métodos relacionados ao tratamento de distúrbios fincionais do intestino e composição farmacêutica |
ATE359079T1 (de) * | 2003-01-13 | 2007-05-15 | Dynogen Pharmaceuticals Inc | Verfahren zur behandlung von übelkeit, erbrechen, würgereiz oder jede kombination daraus |
ATE365554T1 (de) * | 2003-04-04 | 2007-07-15 | Dynogen Pharmaceuticals Inc | Methode zur behandlung von erkrankungen der unteren harnwege |
US7820690B2 (en) * | 2004-03-19 | 2010-10-26 | Solvay Pharmaceuticals Gmbh | Method of treating or inhibiting a non-digestive tract derived abdominal disorder associated with pain using a 5-HT, receptor antagonist |
US20060293309A1 (en) * | 2005-03-28 | 2006-12-28 | Dynogen Pharmaceuticals, Inc. | Method of treating disorders and conditions using peripherally-restricted antagonists and inhibitors |
JPWO2010018866A1 (ja) * | 2008-08-14 | 2012-01-26 | 杏林製薬株式会社 | 安定化された医薬組成物 |
EP4062973A4 (en) | 2019-11-20 | 2023-11-29 | Shionogi & Co., Ltd | SOLID FORMULATION CONTAINING 6,7-UNSATURATED-7-CARBAMOYL MORPHINAND DERIVATIVE |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0297651B1 (en) * | 1987-06-29 | 1993-11-03 | Duphar International Research B.V | Anellated indole derivatives |
DE4238553A1 (de) * | 1992-11-14 | 1994-05-19 | Kali Chemie Pharma Gmbh | Neue Imidazol-1-yl-Verbindungen enthaltende Arzneimittel |
AU702594B2 (en) * | 1995-10-13 | 1999-02-25 | Duphar International Research B.V. | Process for the preparation of enantiomerically pure imidazolyl compounds |
-
1998
- 1998-03-27 DE DE19813661A patent/DE19813661A1/de not_active Withdrawn
- 1998-06-05 CN CN98109652A patent/CN1117565C/zh not_active Expired - Fee Related
- 1998-06-17 TW TW087109651A patent/TW509570B/zh not_active IP Right Cessation
- 1998-06-18 AR ARP980102904A patent/AR010178A1/es active IP Right Grant
- 1998-07-11 KR KR10-1998-0028014A patent/KR100515201B1/ko not_active IP Right Cessation
- 1998-07-15 DZ DZ980170A patent/DZ2560A1/xx active
- 1998-07-20 IL IL12540398A patent/IL125403A/en not_active IP Right Cessation
- 1998-07-22 DK DK98113643T patent/DK0895782T3/da active
- 1998-07-22 AT AT98113643T patent/ATE283706T1/de active
- 1998-07-22 EP EP98113643A patent/EP0895782B1/de not_active Expired - Lifetime
- 1998-07-22 ES ES98113643T patent/ES2234051T3/es not_active Expired - Lifetime
- 1998-07-22 DE DE59812317T patent/DE59812317D1/de not_active Expired - Lifetime
- 1998-07-22 PT PT98113643T patent/PT895782E/pt unknown
- 1998-07-23 TR TR1998/01432A patent/TR199801432A3/tr unknown
- 1998-07-24 SK SK1009-98A patent/SK284916B6/sk not_active IP Right Cessation
- 1998-07-24 NZ NZ331083A patent/NZ331083A/xx not_active IP Right Cessation
- 1998-07-27 CZ CZ19982367A patent/CZ295072B6/cs not_active IP Right Cessation
- 1998-07-28 ZA ZA986715A patent/ZA986715B/xx unknown
- 1998-07-29 RU RU98114668/14A patent/RU2199318C2/ru not_active IP Right Cessation
- 1998-07-29 HU HU9801712A patent/HUP9801712A3/hu unknown
- 1998-07-31 AU AU78630/98A patent/AU743043B2/en not_active Ceased
- 1998-07-31 BR BR9803730-7A patent/BR9803730A/pt not_active Application Discontinuation
- 1998-07-31 JP JP21707598A patent/JP4324260B2/ja not_active Expired - Fee Related
- 1998-07-31 NO NO19983540A patent/NO323229B1/no not_active IP Right Cessation
- 1998-07-31 CA CA002244389A patent/CA2244389C/en not_active Expired - Fee Related
- 1998-07-31 UA UA98074202A patent/UA62924C2/uk unknown
- 1998-07-31 PL PL327786A patent/PL191767B1/pl not_active IP Right Cessation
- 1998-07-31 US US09/126,751 patent/US5977127A/en not_active Expired - Lifetime
- 1998-08-03 ID IDP981075A patent/ID20685A/id unknown
-
1999
- 1999-06-30 HK HK99102775A patent/HK1017611A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR010178A1 (es) | Preparados farmaceuticos que contienen como principio activo cilansetron, empleo de aditivos y procedimiento para la produccion de dichos preparados | |
ES2543977T3 (es) | Sistema terapéutico transdérmico para la administración del principio activo buprenorfina | |
PE20050822A1 (es) | Derivados de florfenicol con mejor solubilidad en agua | |
UY26496A1 (es) | Composiciones farmacéuticas que proporcionan concentraciones potenciadas de fármaco | |
SV2002000197A (es) | Nuevos derivados de biarileter utiles como inhibidores de la recaptacion de monoaminas ref. pc10602/20073/bb | |
ECSP055747A (es) | Antagonistas de cgrp elegidos, procedimiento para su preparación, así como su empleo como medicamentos | |
AR034897A1 (es) | Derivados n-monoacilados de o-fenilendiaminas, sus analogos heterociclicos de seis miembros y su uso como agentes farmaceuticos | |
ECSP055746A (es) | Antagonistas de cgrp elegidos, procedimiento para su preparación, así como su empleo como medicamentos | |
PE20010982A1 (es) | Composicion estable para dosis oral de liberacion extendida | |
AR246755A1 (es) | Una composicion para el tratamiento de las superficies de los suelos. | |
PE20070800A1 (es) | Uso de flibanserina para el tratamiento de trastornos del deseo sexual premenopausicos | |
BR0014486A (pt) | Composições farmacêuticas contendo polipeptìdeo lìquido estabilizado | |
AR065797A1 (es) | Usos y derivados de 1-(2- (2,4- dimetilfenilsulfanil) fenil) piperazina | |
CU23260B7 (es) | PREPARADO FARMACéUTICO DE MOXIFLOXACINA | |
AR027714A1 (es) | Uso de sales metalicas para estabilizar composiciones de taxanos. | |
AR009911A1 (es) | Derivados de acido benzazepinona-n-acetico, sustituidos con acidos fosfonicos, asi como procedimientos para su preparacion y medicamentos que contienen estos compuestos | |
ES2192256T3 (es) | Soluciones farmaceuticas inyectables que contienen paracetamol y combinaciones de paracetamol con otras sustancias activas. | |
CO5011082A1 (es) | Formulacion medicamentosa con liberacion controlada de sus- tancia activa | |
ES2109131B1 (es) | Composicion farmaceutica que tiene actividad analgesica. | |
ATE430571T1 (de) | Wässrige pharmazeutische formulierungen von wasserlöslichen prodrugs von propofol- verbindungen | |
ES2031900T3 (es) | Un procedimiento para la produccion de antibioticos de eter policiclicos. | |
PE20030092A1 (es) | Formulacion de una solucion de inhalacion con una sal de tiotropio | |
SV2006002223A (es) | Composicion farmaceutica ref. bhco41369-sv | |
UY25071A1 (es) | Composiciones solubilizadas de sertralina | |
ES2183158T3 (es) | Poli(acidos organicos) y sus analogos para aumentar la eficacia herbicida. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant, registration |